Conference Reports for NATAP

65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014 Back

ACH-3422, A Novel HCV NS5B RNA Polymerase Nucleotide Inhibitor, Demonstrates Improved Potency Over Sofosbuvir Against HCV Genotype-3 Replicons In Vitro       Reported by Jules Levin AASLD 2014   Yongsen Zhao, Steven Podos, Joanne Fabrycki, Dharaben Patel, Wengang Yang, Guangwei Yang, Jason Wiles, Avinash Phadke and Mingjun Huang Achillion Pharmacueticals